The Human Protein Atlas and Precision Medicine
Can't see this email? View it online
   
  Prostate Cancer  
  The latest prostate cancer news from News Medical  
 Supercharge your health with carotenoidsSupercharge your health with carotenoids
 
This review highlights carotenoids' various biological activities, including antioxidant, anti-tumor, anti-diabetic, anti-aging, and anti-inflammatory effects, with a specific focus on lycopene.
 
 
 The Human Protein Atlas and Precision MedicineThe Human Protein Atlas and Precision Medicine
 
In this interview, Mathias Uhlen, the Director of the Human Protein Atlas, talks to NewsMed about the Human Protein Atlas and Precision Medicine.
 
   UC San Diego Health offers a new minimally invasive biopsy procedure to detect prostate cancerUC San Diego Health offers a new minimally invasive biopsy procedure to detect prostate cancer
 
UC San Diego Health is the first health system in San Diego County to offer a new minimally invasive prostate biopsy procedure that reduces the risk of infection, improves imaging for accuracy and may increase cancer detection in a clinic setting.
 
   OncoAssure announces results of clinical study on novel prostate cancer testOncoAssure announces results of clinical study on novel prostate cancer test
 
OncoAssure today announced that results of its clinical study validating OncoAssure Prostate, a novel test for prostate cancer management, have been published in European Urology Focus, a peer-reviewed and open access journal.
 
   Shared decision policies lead to high rates of PSA testing and inequity with minimal benefitShared decision policies lead to high rates of PSA testing and inequity with minimal benefit
 
Most high income countries, including the UK, do not have a national prostate cancer screening programme, but instead allow men without symptoms to get a prostate-specific antigen (PSA) test if they wish, after talking to their doctor.
 
 New CAR T strategy offers a dual-targeting mechanism to fight bone metastatic prostate cancer
 
New CAR T strategy offers a dual-targeting mechanism to fight bone metastatic prostate cancerProstate cancer frequently metastasizes to the bone and is incurable. Moffitt Cancer Center researchers are working to identify new treatment options for this subset of patients.
 
 
 Study offers new insights into neuroendocrine transdifferentiation in breast and prostate cancer biology
 
Study offers new insights into neuroendocrine transdifferentiation in breast and prostate cancer biologyA new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 8, entitled, "The senescence-associated secretory phenotype induces neuroendocrine transdifferentiation."